Insights on the Microbial Contract Biomanufacturing Global Market to 2030 - Featuring AGC Biologics, Aldevron and BioVectra Among Others
December 10, 2020 06:53 ET
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Microbial Contract Biomanufacturing Market across Type of Biologic, Type of Microbial Expression System Used, Scale of Operation, End User, and Key...
Stem Holdings, Inc. Announces "On Your Mark" Quick Start to 2021 Expansion
December 08, 2020 08:00 ET
|
Stem Holdings, Inc
Stem to Launch 12 New Products in January Featuring, Cannabis-Infused Topicals, and a new CBD Product Line-Up from Patent Edibles -Pending Hemp Genetics Acquisition of Driven Deliveries to...
Contract Development Service Market Is Anticipated to Grow US$ 4.4 Bn by 2027: Acumen Research and Consulting
December 07, 2020 07:33 ET
|
Acumen Research and Consulting
Global Contract Development Service Market - High R&D activities related to biologics and players approach towards outsourcing are major factors expected to drive the growth. LOS ANGELES, Dec. ...
Seasonal Probiotics Company Jetson Adds Leading Pediatrician and OBGYN to Advisory “Gut Council”
November 11, 2020 09:03 ET
|
Jetson
CHICAGO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Jetson, creators of the world’s only seasonal probiotic, today announced the addition of two new medical experts to their Gut Council, a group of top...
MasterControl Recognizes Customers’ Achievements
October 22, 2020 08:00 ET
|
MasterControl Inc.
SALT LAKE CITY, Oct. 22, 2020 (GLOBE NEWSWIRE) -- MasterControl, a provider of software solutions that enable life sciences and other regulated companies to deliver life-changing products to more...
XOMA Reports Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
XOMA Corporation
EMERYVILLE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), today announced its second quarter 2020 royalty asset portfolio advancements and financial results. “With a...
COVID-19 Drugs and Vaccines - Complete Details of Pipeline Drugs Including the Development Phase, Companies Involved, Clinical Trial Developments, and Other Details
May 28, 2020 04:03 ET
|
Research and Markets
Dublin, May 28, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Drug and Vaccine Pipeline Current Status Report: May 2020 Update" report has been added to ResearchAndMarkets.com's offering. ...
XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights
March 10, 2020 07:30 ET
|
XOMA Corporation
Added more than 20 new partner-funded programs in 2019 with potential for milestone and royalty payments Received $15.8 million from partners during the year Current cash balance sufficient to fund...
CORRECTING and REPLACING -- XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
November 05, 2019 10:59 ET
|
XOMA Corporation
EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by XOMA Corporation (Nasdaq: XOMA) please note that in the fifth paragraph of the...
XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
November 05, 2019 08:20 ET
|
XOMA Corporation
EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today reported its third quarter 2019 financial results. “XOMA’s portfolio of future potential royalty- and...